Mounjaro vs Zepbound: same molecule, different FDA indications Mounjaro and Zepbound are the same drug both are tirzepatide manufactured by Eli Lilly, at the same doses (2.5 mg through 15 mg), with the same six-step escalation schedule, and dispensed in the same KwikPen injector format
Endocrinology 109 , 279283 (1981)
As a 15-amino-acid peptide derived from human gastric juice, it demonstrates reasonable stability in solution
9.7 % in the placebo group
Research shows it may be effective for improving insulin resistance, reducing body weight and lowering lipid levelssuggesting berberine as a natural option for supporting weight loss
Observational meta-analyses focused mostly converged on a modestly increased relative risk of NAION